LEADER 05257nam 2200601 450 001 9910813406403321 005 20230803034305.0 010 $a90-6299-861-5 035 $a(CKB)3710000000082900 035 $a(EBL)1600436 035 $a(SSID)ssj0001154407 035 $a(PQKBManifestationID)11741586 035 $a(PQKBTitleCode)TC0001154407 035 $a(PQKBWorkID)11163068 035 $a(PQKB)10236323 035 $a(MiAaPQ)EBC1600436 035 $a(Au-PeEL)EBL1600436 035 $a(CaPaEBR)ebr10824186 035 $a(OCoLC)869095464 035 $a(EXLCZ)993710000000082900 100 $a20140111d2013 uy| 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt 182 $cc 183 $acr 200 10$aCholesteatoma and ear surgery $ean update /$fedited by Haruo Takahashi 210 1$aAmsterdam :$cKugler Publications,$d2013. 215 $a1 online resource (508 p.) 300 $a"Proceedings of the 9th International Conference on Cholesteatoma and Ear Surgery. June 3-7, 2012, Nagasaki, Japan." 311 $a90-6299-237-4 320 $aIncludes bibliographical references and index. 327 $aTable of Contents; PREFACE; KEYNOTE LECTURES; PREVENTIVE MEASURES AGAINST CHOLESTEATOMA RECURRENCE IN CANAL-WALL-UP TYMPANOPLASTY: STAGING THE OPERATION AND CHOICE OF MASTOID OBLITERATION; MANAGEMENT STRATEGY FOR CHRONIC OTITIS MEDIA WITH CHOLESTEATOMA IN 2012; SYMPOSIA; EPIDEMIOLOGICAL STUDY ON CHOLESTEATOMA IN FUKUOKACITY TO REVEAL THE PATHOGENESIS OF CHOLESTEATOMA; THE ROLE OF THE MASTOID IN MIDDLE EAR PRESSURE REGULATION; MIDDLE EAR PRESSURE NEURAL FEEDBACK CONTROL; EVALUATION OF ENDOLYMPHATIC HYDROPS ON MAGNETICRESONANCE IMAGING IN PATIENTS WITH OTOSCLEROSIS 327 $aCHOLESTEATOMA GROWTH AND PROLIFERATION:EXPRESSION OF HGF (HEPATOCYTE GROWTH FACTOR) AND ITS HIGH-AFFINITY RECEPTOR C-METREGULATING OSTEOCLASTS FOR THE MAINTENANCE OF AUDITORY OSSICULAR MORPHOLOGY, THE MIDDLE EAR ANDHEARING; SURGICAL TREATMENTS FOR PATULOUS EUSTACHIAN TUBE:AUTOLOGOUS FAT GRAFTING AND ARTIFICIAL EUSTACHIANTUBE; LONG-TERM EUSTACHIAN TUBE DYSFUNCTION IN POSTRADIOTHERAPYNASOPHARYNGEAL CARCINOMA PATIENTS; PANEL DISCUSSIONS; TYMPANOPLASTY WITH SOFT POSTERIOR MEATAL WALLRECONSTRUCTION: CHANGING THE WAY OF THINKING FORPREVENTION OF RETRACTION POCKET RECURRENCE 327 $aMETHODS FOR PREVENTION OF RECURRENT CHOLESTEATOMA CWU, CWD - RECONSTRUCTION OR OBLITERATION?; EVALUATION OF MIDDLE EAR PNEUMATIZATION AFTER PLANNED TWO-STAGED TYMPANOPLASTY FOR CHOLESTEATOMA: ITS CORRELATIONS WITH HEARINGRESULTS AND RECURRENCE RATES; HOW TO DEAL WITH CHOLESTEATOMA IN A DEVELOPING COUNTRY; FACIAL-NERVE TUMOR COMBINED WITH CHOLESTEATOMA; A PROPOSAL ON THE CLASSIFICATION SYSTEM OF AURALCHOLESTEATOMA IN KOREA; ADVOCATING THE USE OF THE TERM EOSINOPHILIC OTITIS MEDIA (EOM); EOSINOPHILIC RHINOSINUSITIS AND OTITIS MEDIA INPATIENTS WITH ASTHMA - FOCUS ON EOSINOPHILIC NASALPOLYPOSIS 327 $aFROM RETRACTION POCKETS INTO EARLY-STAGE CHOLESTEATOMA: PATHOGENESIS AND MANAGEMENT ON-DEMAND SURGICAL TECHNIQUE FOR CHOLESTEATOMA: ATTIC EXPOSITION ANTRUM EXCLUSION; USE OF CARTILAGE IN TYMPANOPLASTY; TREATMENT OF CHOLESTEATOMA-INDUCED LABYRINTHINE FISTULA; EFFICACY OF 3D FLAIR MRI FINDINGS IN EVALUATING CHOLESTEATOMA WITH LABYRINTHINE FISTULAE; STAPES SURGERY AND COCHLEAR IMPLANT SURGERY FOR SEVERE ORTOSCLEROSIS; TREATMENT OF SEVERE OTOSCLEROSIS: COCHLEAR IMPLANTATION, STAPEDOTOMY, AND OTHER OPTIONS; BILATERAL CONGENITAL AURAL ATRESIA: SURGICALRECONSTRUCTION VS. BAHA IMPLANTATION 327 $aFACIAL PARALYSIS IN CHRONIC OTITIS MEDIA FACTORS INFLUENCING HEARING AFTER TYPE-III TYMPANOPLASTY USING COLUMELLA; OUTCOME OF RADICAL SURGERY AND POST-OPERATIVE RADIOTHERAPY FOR SQUAMOUS CARCINOMA OF THE TEMPORAL BONE; SURGICAL MANAGEMENT OF T1 AND T2 LESIONS WITH OUTCOMES; CONGENITAL CHOLESTEATOMA: RADIOLOGIC EVALUATION AND PERSONAL EXPERIENCE; SURGICAL MANAGEMENT OF PETROUS APEX CHOLESTEATOMA: OUR EXPERIENCE OF 15 CASES; CONGENITAL CHOLESTEATOMA OF THE MIDDLE EAR: A REPORT OF 54 CASES; THE INFLUENCE OF MIDDLE EAR INFECTIONS ON CHARACTERISTICS OF CONGENITAL CHOLESTEATOMA; MINI LECTURES 327 $aCONSERVATIVE TREATMENT OF CHOLESTEATOMA BY 5-FUOINTMENT 330 $aPreface It was indeed a great pleasure and honor for me to have hosted the 9th International Conference on Cholesteatoma and Ear Surgery in Nagasaki, Japan. There were 558 participants; four full-day programs provided them with rich scientific programs including six keynote lectures, seven symposia, 26 panel discussions, 12 mini lectures on recent topics, 23 instruction courses, two live cadaver temporal-bone dissections, three sponsored sessions, three other sessions, and three days of temporal-bone dissection courses. I would like to take this opportunity to express my greatest gratitude to a 606 $aCholesteatoma$vCongresses 606 $aEar$xSurgery$vCongresses 615 0$aCholesteatoma 615 0$aEar$xSurgery 676 $a617.8 676 $a617.84 701 $aTakahashi$b Haruo$01604938 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910813406403321 996 $aCholesteatoma and ear surgery$93929923 997 $aUNINA